Lord's Mark opens new IVD manufacturing facility ahead of schedule

Lord's Mark Industries Ltd. announced the establishment of a new state-of-the-art In Vitro Diagnostics (IVD) manufacturing facility spanning 14,000 sq. ft. Unit at Vasai (East), Maharashtra.

Originally slated to begin operations in August 2026, the unit has been brought online two months ahead of schedule, a reflection of the management's execution focus and operational discipline.The new facility complements Lord's Mark's existing 20,000 sq. ft. manufacturing unit, taking the company's total operational manufacturing space to 34,000 sq. ft. The expanded capacity is designed to enhance production throughput, improve operational efficiency, and meet the rising demand for high-quality diagnostic solutions across domestic and international markets.

The unit will manufacture a portfolio of 56 ELISA test kits alongside a new range of rapid test kits, broadening the company's product basket while maintaining stringent quality standards and accelerating availability to customers.Beyond manufacturing, the facility carries a deeper purpose. The facility's Research & Development division has been dedicated to the memory of Ratan Tata and will serve as the centrepiece of what the company describes as one of India's dedicated indigenous molecular biology research programmes in genetic science.

The initiative aims to strengthen domestic scientific capabilities in a field that has historically depended heavily on imported technologies and expertise.

The company also shared its forward roadmap. A third facility, to be set up in Vasai, Maharashtra, will be established as a dedicated centre of research for the early detection of cancer, and will be dedicated to the late President of India, Dr APJ Abdul Kalam.

This unit is expected to become operational from January 2029.Looking ahead, Lord's Mark Industries has outlined plans to establish one of the world's largest medical device manufacturing facilities in India, with a focus on AI-enabled and imaging-based diagnostic technologies. The move reflects the company's broader ambition to strengthen India's position in the global medical technology manufacturing landscape.Sachidanand Upadhyay, Managing Director, Lord's Mark Industries Ltd., said, "Every milestone we mark is guided by a simple conviction, that world-class healthcare must be built in India, for India and the world. Deeply inspired by the vision of the late Shri Ratan Tata, we are committing our research, our capacity and our purpose to outcomes that matter: indigenous science, earlier cancer detection, and devices that make quality diagnosis accessible to all.

We have everything it takes to become the world's partner in wellness and we will."The investment underscores Lord's Mark Industries' broader ambitions in the in-vitro diagnostics (IVD) sector, where the company is seeking to expand its manufacturing capabilities through a combination of innovation, quality-focused processes and long-term infrastructure development. As demand for advanced diagnostic solutions continues to grow, the company aims to play a larger role in strengthening healthcare delivery and supporting better patient outcomes.Disclaimer - The above content is non-editorial, and TIL hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content.